Description
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from α-MSH, structurally optimized for central nervous system activity rather than peripheral pigmentation effects. A primary reference compound in melanocortin-system and central sexual-response research.
Reviews
There are no reviews yet.